Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.690
-0.070 (-1.86%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Apyx Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Apyx Medical stock have an average target of 6.50, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 76.15% from the current stock price of 3.69.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $6.50 $6.00 $8.00
Change +62.60% +76.15% +62.60% +116.80%
* Price targets were last updated on Mar 11, 2026.

Analyst Ratings

The average analyst rating for Apyx Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 011133
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 122244

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$5$6
Strong Buy Maintains $5$6 +62.60% Mar 11, 2026
BTIG
BTIG
Strong Buy
Upgrades
$6
Strong Buy Upgrades $6 +62.60% Mar 11, 2026
Roth Capital
Roth Capital
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +62.60% Dec 16, 2025
Citizens
Citizens
Buy
Upgrades
$8
Buy Upgrades $8 +116.80% Nov 12, 2025
BTIG
BTIG
Hold
Initiates
n/a
Hold Initiates n/a n/a Oct 17, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
59.15M
from 52.84M
Increased by 11.93%
Revenue Next Year
65.66M
from 59.15M
Increased by 11.01%
EPS This Year
-0.32
from -0.27
EPS Next Year
-0.28
from -0.32
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
48.52M44.51M52.35M48.10M52.84M59.15M65.66M
Revenue Growth
75.08%-8.26%17.61%-8.11%9.86%11.93%11.01%
EPS
-0.44-0.67-0.54-0.66-0.27-0.32-0.28
EPS Growth
-------
Forward PE
-------
No. Analysts -----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030
High 61.2M 69.3M
Avg 59.1M 65.7M
Low 56.4M 60.5M

Revenue Growth

Revenue Growth 20262027202820292030
High
15.8%
17.2%
Avg
11.9%
11.0%
Low
6.8%
2.4%

EPS Forecast

EPS 20262027
High -0.32 -0.21
Avg -0.32 -0.28
Low -0.34 -0.35

EPS Growth

EPS Growth 20262027
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.